OptimizeRx (OPRX)
(Delayed Data from NSDQ)
$12.15 USD
-0.51 (-4.03%)
Updated May 29, 2024 04:00 PM ET
After-Market: $12.17 +0.02 (0.16%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth F Momentum D VGM
Brokerage Reports
0 items in cart
OptimizeRx Corp. [OPRX]
Reports for Purchase
Showing records 81 - 100 ( 124 total )
Company: OptimizeRx Corp.
Industry: Computer - Software
New Partnership Adds Expansion to Two Largest Hospital EHRs; PT to $25.00
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: OptimizeRx Corp.
Industry: Computer - Software
Hard to Argue With Strong Growth - Profitability; PT Increased to $22.50
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: OptimizeRx Corp.
Industry: Computer - Software
We are initiating coverage with a Buy rating and $18.00 price target
Provider: Roth Capital Partners, Inc.
Analyst: BALDRY R
Company: OptimizeRx Corp.
Industry: Computer - Software
Company: OptimizeRx Corp.
Industry: Computer - Software
Solid 3Q:16 Results Support Our Outlook For Accelerated Revenue Growth Through 2017
Provider: Merriman Curhan Ford & Co.
Company: OptimizeRx Corp.
Industry: Computer - Software
Expect Aggressive Sales Efforts, Product Line Expansion To Cement OPRX''s Leading Position In E-RX Space
Provider: Merriman Curhan Ford & Co.
Company: OptimizeRx Corp.
Industry: Computer - Software
Beefed-Up Leadership, Financial Strength And Powerful Partners Underpin Our BUY Rating On OPRX
Provider: Merriman Curhan Ford & Co.
Company: OptimizeRx Corp.
Industry: Computer - Software
3Q:15 Results Boast Double-Digit Revenue Growth, GAAP Profitability And Investment From Powerful Ally
Provider: Merriman Curhan Ford & Co.
Company: OptimizeRx Corp.
Industry: Computer - Software
Think Minority Investment By WPP Is Strong Validation Of OPRX''s Market Opportunity; Reiterate BUY
Provider: COLLIERS SECURITIES
Company: OptimizeRx Corp.
Industry: Computer - Software
OPRX Solidifies Distribution Lead With Exclusive Partnership With Allscripts; Reiterate BUY
Provider: Merriman Curhan Ford & Co.
Company: OptimizeRx Corp.
Industry: Computer - Software
Progress On Multiple Fronts Supports Our Outlook For Accelerated Revenue Growth In 2H:15; Reiterate BUY
Provider: Merriman Curhan Ford & Co.
Company: OptimizeRx Corp.
Industry: Computer - Software
In-Line 1Q:15 Revenue, Positive Cash Flow Boost Cash Balance; Channel Expansion On Track; Maintain BUY
Provider: Merriman Curhan Ford & Co.
Company: OptimizeRx Corp.
Industry: Computer - Software
Look For March-Quarter Revenue Up 16% Year Over Year; Channel Expansion Continues; Reiterate BUY
Provider: Merriman Curhan Ford & Co.
Company: OptimizeRx Corp.
Industry: Computer - Software
The Fragmented EHR Landscape Is Ripe For Intermediation
Provider: Merriman Curhan Ford & Co.
Company: OptimizeRx Corp.
Industry: Computer - Software
4Q:14 Revenue In Line With Our Estimate; Look For Sharp Uptick In Y/Y Sales Growth In 1Q:15
Provider: Merriman Curhan Ford & Co.
Company: OptimizeRx Corp.
Industry: Computer - Software
Integration With Practice Fusion Extends Unparalleled Reach Into Physicians; Reiterate BUY
Provider: Merriman Curhan Ford & Co.
Company: OptimizeRx Corp.
Industry: Computer - Software
Moderated Revenue, Gross Margin Assumptions Lower Our Target To $2.00
Provider: Merriman Curhan Ford & Co.